These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34719645)

  • 1. Temozolomide Induces Endocytosis of EGFRvIII via p38-Mediated Non-canonical Phosphorylation in Glioblastoma Cells.
    Haryuni RD; Tanaka T; Takahashi JI; Onuma I; Zhou Y; Yokoyama S; Sakurai H
    Biol Pharm Bull; 2021; 44(11):1681-1687. PubMed ID: 34719645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma.
    Blomquist MR; Eghlimi R; Beniwal A; Grief D; Nascari DG; Inge L; Sereduk CP; Tuncali S; Roos A; Inforzato H; Sharma R; Pirrotte P; Mehta S; Fortin Ensign SP; Loftus JC; Tran NL
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GARNL3 identified as a crucial target for overcoming temozolomide resistance in EGFRvIII-positive glioblastoma.
    Ling YZ; Luo JR; Cheng SJ; Meng XP; Li JY; Luo SY; Zhong ZH; Jiang XC; Wang X; Ji YQ; Tu YY
    Am J Transl Res; 2024; 16(5):1550-1567. PubMed ID: 38883343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide.
    Vincent CA; Nissen I; Dakhel S; Hörnblad A; Remeseiro S
    BMC Cancer; 2023 Oct; 23(1):945. PubMed ID: 37803333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway.
    Tomas A; Vaughan SO; Burgoyne T; Sorkin A; Hartley JA; Hochhauser D; Futter CE
    Nat Commun; 2015 Jun; 6():7324. PubMed ID: 26066081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-specific p38 MAPK activation is sufficient to drive EGFR endocytosis but not its nuclear translocation.
    Tomas A; Jones S; Vaughan SO; Hochhauser D; Futter CE
    J Cell Sci; 2017 Aug; 130(15):2481-2490. PubMed ID: 28646091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.
    Karpel-Massler G; Wirtz CR; Halatsch ME
    Molecules; 2010 Jun; 15(7):4670-8. PubMed ID: 20657384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the role and targeting of EGFRvIII.
    Bagchi A; Stayrook SE; Xenaki KT; Starbird CA; Doulkeridou S; El Khoulati R; Roovers RC; Schmitz KR; van Bergen En Henegouwen PMP; Ferguson KM
    Structure; 2024 Jun; ():. PubMed ID: 38908376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
    Bi J; Khan A; Tang J; Armando AM; Wu S; Zhang W; Gimple RC; Reed A; Jing H; Koga T; Wong IT; Gu Y; Miki S; Yang H; Prager B; Curtis EJ; Wainwright DA; Furnari FB; Rich JN; Cloughesy TF; Kornblum HI; Quehenberger O; Rzhetsky A; Cravatt BF; Mischel PS
    Cell Rep; 2021 Nov; 37(5):109957. PubMed ID: 34731610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response.
    Matteoni S; Matarrese P; Ascione B; Ricci-Vitiani L; Pallini R; Villani V; Pace A; Paggi MG; Abbruzzese C
    J Exp Clin Cancer Res; 2021 Nov; 40(1):347. PubMed ID: 34740374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with
    Duff S; Bargiacchi F; Norregaard C; Brener M; Sullivan E
    J Manag Care Spec Pharm; 2022 Feb; 28(2):218-231. PubMed ID: 34726500
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival.
    Huang B; Yu Z; Liang R
    BMC Neurol; 2021 Nov; 21(1):424. PubMed ID: 34724914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population.
    Kim NY; Hwang SH; Yang Y; Kim Y
    Oncol Lett; 2021 Dec; 22(6):845. PubMed ID: 34733363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data.
    Zhang X; Jin F; Jiang S; Cao J; Meng Y; Xu Y; ChunmengWang ; Chen Y; Yang H; Kong Y; Liu X; Luo Z
    Invest New Drugs; 2022 Apr; 40(2):453-460. PubMed ID: 34731354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With
    Tada H; Mitsudomi T; Misumi T; Sugio K; Tsuboi M; Okamoto I; Iwamoto Y; Sakakura N; Sugawara S; Atagi S; Takahashi T; Hayashi H; Okada M; Inokawa H; Yoshioka H; Takahashi K; Higashiyama M; Yoshino I; Nakagawa K;
    J Clin Oncol; 2022 Jan; 40(3):231-241. PubMed ID: 34726958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells.
    Zampieri LX; Sboarina M; Cacace A; Grasso D; Thabault L; Hamelin L; Vazeille T; Dumon E; Rossignol R; Frédérick R; Sonveaux E; Lefranc F; Sonveaux P
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of gefitinib in synergism with thymoquinone
    Upadhyay P; Ghosh A; Basu A; Pranati PA; Gupta P; Das S; Sarker S; Bhattacharjee M; Bhattacharya S; Ghosh S; Chattopadhyay S; Adhikary A
    Biomater Sci; 2021 Dec; 9(24):8285-8312. PubMed ID: 34766965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model.
    Zorrilla-Vaca A; Rice D; Brown JK; Antonoff M; Sepesi B; Hofstetter W; Swisher S; Walsh G; Vaporciyan A; Mehran R; Hagberg C; Mena GE
    Surgery; 2022 Feb; 171(2):504-510. PubMed ID: 34740455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the degree of brain edema regression and changes in cognitive function in patients with recurrent glioma treated with bevacizumab and temozolomide.
    Wang X; Chen D; Qiu J; Li S; Zheng X
    Quant Imaging Med Surg; 2021 Nov; 11(11):4556-4568. PubMed ID: 34737923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.